Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Dec;11(4):459-67.
doi: 10.1007/s11904-014-0232-x.

Modeling the implementation of universal coverage for HIV treatment as prevention and its impact on the HIV epidemic

Roger Ying  1 , Ruanne V Barnabas, Brian G Williams
Affiliations
Review

Modeling the implementation of universal coverage for HIV treatment as prevention and its impact on the HIV epidemic

Roger Ying et al. Curr HIV/AIDS Rep. 2014 Dec.

Abstract

The Joint United Nations Programme on HIV/AIDS (UNAIDS) recently updated its global targets for antiretroviral therapy (ART) coverage for HIV-positive persons under which 90 % of HIV-positive people are tested, 90 % of those are on ART, and 90 % of those achieve viral suppression. Treatment policy is moving toward treating all HIV-infected persons regardless of CD4 cell count-otherwise known as treatment as prevention-in order to realize the full therapeutic and preventive benefits of ART. Mathematical models have played an important role in guiding the development of these policies by projecting long-term health impacts and cost-effectiveness. To guide future policy, new mathematical models must consider the barriers patients face in receiving and taking ART. Here, we describe the HIV care cascade and ART delivery supply chain to examine how mathematical modeling can provide insight into cost-effective strategies for scaling-up ART coverage in sub-Saharan Africa and help achieve universal ART coverage.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Successful care for an HIV-positive person begins with identifying their HIV-infection status and continues through viral suppression and clinical support
Fig. 2
Fig. 2
The HIV supply chain encompasses different levels of government (e.g. national, regional) and different processes (e.g. supply pick-up and delivery)
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Palmer S, Maldarelli F, Wiegand A, Bernstein B, Hanna GJ, Brun SC, et al. Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy. Proc Natl Acad Sci U S A. 2008;105:3879–3884. - PMC - PubMed
    1. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493–505. [This paper describes the results of the first randomized study of early ART treatment for preventing HIV transmission (HPTN 052) which demonstrated a 96% reduction in the risk of HIV transmission with early ART provision.] - PMC - PubMed
    1. Delva W, Eaton JW, Meng F, Fraser C, White RG, Vickerman P, et al. HIV treatment as prevention: optimising the impact of expanded HIV treatment programmes. PLoS Med. 2012;9:e1001258. - PMC - PubMed
    1. Sidibé M, Zuniga JM, Montaner J. Leveraging HIV Treatment to End AIDS, Stop New HIV Infections, and Avoid the Cost of Inaction. Clin Infect Dis. 2014;59(Suppl 1):S3–6. - PMC - PubMed
    1. Tanser F, Bärnighausen T, Grapsa E, Zaidi J, Newell ML. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science. 2013;339:966–971. - PMC - PubMed

Substances